• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Lyell Immunopharma

Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility

April 5, 2021
Crossover Health, Inc.

Crossover Health banks $168M Series D

April 5, 2021
Genomics PLC

Oxford’s Genomics Pushing the Boundaries of Personalized Medicine

April 2, 2021
Genomics PLC

Entrepreneurs: Meet Genomics founder Sir Peter Donnelly as biotech firm takes DNA analysis trials to America

April 2, 2021
Color Health

Inside Color’s big — and highly bankrolled — pivot to public health tech

March 27, 2021
Everly Health

Everlywell acquires two healthcare companies and forms parent Everly Health

March 27, 2021
Maze Therapeutics

Exclusive: Maze unveils their $191M pipeline, taking on Vertex and two long-sought conditions

March 24, 2021
insitro

Insitro raises $400M for machine learning-powered drug discovery efforts

March 15, 2021
Remix Therapeutics

Remix Therapeutics debuts with $81M to ‘reprogram’ disease-causing RNA

December 10, 2020
Everly Health

Demand for at-home testing propels Everlywell to $175M in new funding

December 10, 2020
Page 8 of 26« First«...678910...20...»Last »

Please see important disclaimers in the Terms section.


©2026 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©[current_date] Foresite Capital Management, LLC.

    Site by Goodlab

    Close